KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other Accumulated Expenses (2018 - 2025)

Historic Other Accumulated Expenses for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $13.5 million.

  • Twist Bioscience's Other Accumulated Expenses rose 15688.67% to $13.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.5 million, marking a year-over-year increase of 15688.67%. This contributed to the annual value of $12.1 million for FY2025, which is 10885.34% up from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's Other Accumulated Expenses is $13.5 million, which was up 15688.67% from $12.1 million recorded in Q3 2025.
  • Twist Bioscience's 5-year Other Accumulated Expenses high stood at $20.1 million for Q2 2022, and its period low was $4.1 million during Q1 2021.
  • For the 5-year period, Twist Bioscience's Other Accumulated Expenses averaged around $10.5 million, with its median value being $9.8 million (2021).
  • In the last 5 years, Twist Bioscience's Other Accumulated Expenses soared by 771346.15% in 2021 and then tumbled by 6046.51% in 2023.
  • Quarter analysis of 5 years shows Twist Bioscience's Other Accumulated Expenses stood at $13.9 million in 2021, then increased by 14.19% to $15.8 million in 2022, then tumbled by 59.44% to $6.4 million in 2023, then dropped by 18.32% to $5.2 million in 2024, then soared by 156.89% to $13.5 million in 2025.
  • Its Other Accumulated Expenses was $13.5 million in Q4 2025, compared to $12.1 million in Q3 2025 and $11.1 million in Q2 2025.